Several new selective HDAC6 inhibitors (e.g., various nexturastat A analogs, the isoxazole SS208/AVS100, and the thiazole XP5) were disclosed, which displayed similar immunomodulating properties in melanomas[123-127]. The gene discussed is HDAC6; the disease is melanoma.